Mariner’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,931
| Closed | -$1.04M | – | 1097 |
|
|
2019
Q2 | $1.04M | Buy |
7,931
+213
| +3% | +$27.9K | 0.01% | 529 |
|
|
2019
Q1 | $1.04M | Buy |
7,718
+3,246
| +73% | +$439K | 0.01% | 485 |
|
|
2018
Q4 | $435K | Sell |
4,472
-758
| -14% | -$73.7K | 0.01% | 601 |
|
|
2018
Q3 | $727K | Sell |
5,230
-969
| -16% | -$135K | 0.02% | 490 |
|
|
2018
Q2 | $770K | Buy |
+6,199
| New | +$770K | 0.02% | 457 |
|
|
2018
Q1 | – | Sell |
-4,813
| Closed | -$576K | – | 676 |
|
|
2017
Q4 | $576K | Buy |
4,813
+113
| +2% | +$13.5K | 0.02% | 373 |
|
|
2017
Q3 | $659K | Sell |
4,700
-373
| -7% | -$52.3K | 0.03% | 304 |
|
|
2017
Q2 | $617K | Sell |
5,073
-278
| -5% | -$33.8K | 0.03% | 307 |
|
|
2017
Q1 | $649K | Sell |
5,351
-846
| -14% | -$103K | 0.03% | 342 |
|
|
2016
Q4 | $758K | Buy |
6,197
+372
| +6% | +$45.5K | 0.03% | 305 |
|
|
2016
Q3 | $714K | Buy |
5,825
+135
| +2% | +$16.5K | 0.03% | 308 |
|
|
2016
Q2 | $664K | Sell |
5,690
-4,378
| -43% | -$511K | 0.04% | 290 |
|
|
2016
Q1 | $1.4M | Buy |
10,068
+1,508
| +18% | +$210K | 0.08% | 199 |
|
|
2015
Q4 | $1.63M | Sell |
8,560
-3,115
| -27% | -$594K | 0.1% | 165 |
|
|
2015
Q3 | $1.83M | Buy |
11,675
+415
| +4% | +$64.9K | 0.08% | 177 |
|
|
2015
Q2 | $2.04M | Buy |
11,260
+1,476
| +15% | +$267K | 0.09% | 176 |
|
|
2015
Q1 | $1.7M | Buy |
9,784
+2,150
| +28% | +$373K | 0.14% | 121 |
|
|
2014
Q4 | $1.41M | Sell |
7,634
-1,354
| -15% | -$251K | 0.13% | 141 |
|
|
2014
Q3 | $1.49M | Buy |
8,988
+115
| +1% | +$19.1K | 0.17% | 110 |
|
|
2014
Q2 | $1.39M | Buy |
8,873
+2,838
| +47% | +$443K | 0.15% | 125 |
|
|
2014
Q1 | $918K | Buy |
6,035
+645
| +12% | +$98.1K | 0.12% | 158 |
|
|
2013
Q4 | $716K | Buy |
5,390
+2,085
| +63% | +$277K | 0.09% | 183 |
|
|
2013
Q3 | $384K | Buy |
+3,305
| New | +$384K | 0.07% | 213 |
|